Sequential Scn First Trimester




Test Mnemonic

SEQ1

CPT Codes

  • 84702 - QTY (1)
  • 84163 - QTY (1)

Includes

  • Pregnancy-associated plasma protein (PAPP-A)
  • Human chorionic gonadotropin (hCG)
  • Down Syndrome Screening Risk
  • Trisomy 18 Screening Risk
  • Down Syndrome Age Related Risk
  • Trisomy 18 Age Related Risk

Performing Laboratory

Integrated Genetics/Labcorp


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
3 mLSerumSST (Gold) AmbientSpecimen MUST be drawn between 10.4 - 13.9 weeks gestation. A nuchal translucency (NT) measurement by a FMF or SMFM certified sonographer MUST be included with specimen.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mL     

Stability

Environmental Condition Description
Ambient7 days
Refrigerated14 days
Frozen14 days, 3 freeze/thaw cycles

Days Performed

Mon - Fri

Turnaround Time

3 - 6 days

Methodology

Name Description
Chemiluminescence Immunoassay (CLIA) 

Reference Range

Sequential Screen 1 Interpretation
Sex Age From Age To Type Range Range Unit
       Final result pending second trimester sample 

Special Info

PLEASE NOTE: The performing lab will accept nuchal translucency (NT) measurements only from sonographers certified by the Fetal Medicine Foundation (FMF) or the Society for Maternal Fetal Medicine (SMFM). Please submit certification information before sending specimens for Sequential Screen. Submit an Integrated Genetics requisition. Complete clinical and patient information is required for reporting including: Gravida, Para, SAB, TAB, Ultrasound date, Ultrasound fetal age, Sonographer, NT, CRL, LMP date, EDC date, IVF fertilization date, IVF egg donor age (if applicable), maternal weight, number of fetuses, insulin-dependent diabetic prior to pregnancy?, previous down syndrome pregnancy/child?, family history of NTD?, physician or designee signature.

Clinical Info

Sequential Screen is a two part test that screens for fetal Down syndrome, trisomy 18, and open neural tube defects.